Dashboard
Manage Tickers

JANXJanux Therapeutics, Inc.

Nasdaq januxrx.com


$ 49.73 $ -0.12 (-0.24 %)    

Monday, 16-Sep-2024 15:59:49 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.14 $ -2.10 (-0.44 %)
DIA $ 417.33 $ 2.44 (0.59 %)
SPY $ 562.48 $ 0.83 (0.15 %)
TLT $ 101.29 $ 0.92 (0.92 %)
GLD $ 238.61 $ -0.02 (-0.01 %)
$ 49.89
$ 51.03
$ 49.24 x 112
-- x --
$ 48.86 - $ 51.47
$ 5.65 - $ 65.60
457,184
na
2.6B
$ 2.05
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-30-2024 10-Q
2 05-08-2024 03-31-2024 10-Q
3 03-08-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-10-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-09-2022 06-30-2022 10-Q
10 05-10-2022 03-31-2022 10-Q
11 03-18-2022 12-31-2021 10-K
12 11-09-2021 09-30-2021 10-Q
13 08-10-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cantor-fitzgerald-reiterates-overweight-on-janux-therapeutics-maintains-100-price-target
Cantor Fitzgerald Reiterates Overweight on...
09/16/2024 15:52:35

Cantor Fitzgerald analyst Josh Schimmer reiterates Janux Therapeutics (NASDAQ:JANX) with a Overweight and maintains $100 pri...

navigating-5-analyst-ratings-for-janux-therapeutics
Navigating 5 Analyst Ratings For Janux The...
09/06/2024 16:00:53

stifel-initiates-coverage-on-janux-therapeutics-with-buy-rating-announces-price-target-of-70
Stifel Initiates Coverage On Janux Therape...
09/06/2024 15:27:04

Stifel analyst Bradley Canino initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Buy rating and announces Price T...

hc-wainwright--co-reiterates-buy-on-janux-therapeutics-maintains-63-price-target
HC Wainwright & Co. Reiterates Buy on Janu...
08/19/2024 11:41:17

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Janux Therapeutics (NASDAQ:JANX) with a Buy and maintains ...

analyst-expectations-for-janux-therapeuticss-future
Analyst Expectations For Janux Therapeutic...
08/09/2024 21:00:11

scotiabank-maintains-sector-perform-on-janux-therapeutics-lowers-price-target-to-42
Scotiabank Maintains Sector Perform on Jan...
08/09/2024 20:30:41

Scotiabank analyst George Farmer maintains Janux Therapeutics (NASDAQ:JANX) with a Sector Perform and lowers the price targe...

cantor-fitzgerald-reiterates-overweight-on-janux-therapeutics-maintains-100-price-target
Cantor Fitzgerald Reiterates Overweight on...
08/08/2024 14:48:04

Cantor Fitzgerald analyst Josh Schimmer reiterates Janux Therapeutics (NASDAQ:JANX) with a Overweight and maintains $100 pri...

wedbush-reiterates-outperform-on-janux-therapeutics-maintains-74-price-target
Wedbush Reiterates Outperform on Janux The...
08/08/2024 13:28:22

Wedbush analyst Robert Driscoll reiterates Janux Therapeutics (NASDAQ:JANX) with a Outperform and maintains $74 price target.

janux-therapeutics-q2-eps-011-beats-031-estimate-sales-890m-beat-76744k-estimate
Janux Therapeutics Q2 EPS $(0.11) Beats $(...
08/07/2024 20:05:25

Janux Therapeutics (NASDAQ:JANX) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(...

genedx-leads-russell-2000-this-year-as-it-shifts-to-more-comprehensive-genetic-testing-corrected
GeneDx Leads Russell 2000 This Year As It ...
08/02/2024 18:06:16

GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and r...

genedx-leads-russell-2000-this-year-as-it-shifts-to-more-comprehensive-genetic-testing-corrected
GeneDx Leads Russell 2000 This Year As It ...
08/02/2024 18:06:16

GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and r...

janux-therapeutics-reports-appointment-of-current-board-member-ronald-w-barrett-as-chairperson-jay-lichter-resigns-from-board
Janux Therapeutics Reports Appointment Of ...
07/22/2024 20:02:44

The company announced the appointment of Eric Dobmeier and Natasha Hernday to its Board of Directors.

unitedhealth-posts-better-than-expected-earnings-joins-angiodynamics-bank-of-america--and-other-big-stocks-moving-higher-on-tuesday
UnitedHealth Posts Better-Than-Expected Ea...
07/16/2024 15:09:23

ambarella-posts-upbeat-results-joins-gap-pagerduty-elastic-and-other-big-stocks-moving-higher-on-friday
Ambarella Posts Upbeat Results, Joins Gap,...
05/31/2024 14:40:33

the-latest-analyst-ratings-for-janux-therapeutics
The Latest Analyst Ratings For Janux Thera...
05/30/2024 15:01:15

scotiabank-initiates-coverage-on-janux-therapeutics-with-sector-perform-rating-announces-price-target-of-47
Scotiabank Initiates Coverage On Janux The...
05/30/2024 14:37:19

Scotiabank analyst George Farmer initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Sector Perform rating and ann...

analyst-ratings-for-janux-therapeutics
Analyst Ratings For Janux Therapeutics
05/13/2024 13:00:47

hc-wainwright--co-maintains-buy-on-janux-therapeutics-raises-price-target-to-63
HC Wainwright & Co. Maintains Buy on Janux...
05/13/2024 11:18:18

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Janux Therapeutics (NASDAQ:JANX) with a Buy and raises the ...

cantor-fitzgerald-reiterates-overweight-on-janux-therapeutics-maintains-100-price-target
Cantor Fitzgerald Reiterates Overweight on...
05/09/2024 14:20:09

Cantor Fitzgerald analyst Josh Schimmer reiterates Janux Therapeutics (NASDAQ:JANX) with a Overweight and maintains $100 pri...

wedbush-maintains-outperform-on-janux-therapeutics-raises-price-target-to-74
Wedbush Maintains Outperform on Janux Ther...
05/08/2024 14:43:28

Wedbush analyst Robert Driscoll maintains Janux Therapeutics (NASDAQ:JANX) with a Outperform and raises the price target fro...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION